Friday, July 19, 2024
Stay Updated On The Latest Women's News

Susan G. Komen® and GE Healthcare Partner to Improve Lives and Raise Awareness of Advancements in Diagnostics and Treatment Options for Metastatic Breast Cancer

Susan G. Komen®, the world’s leading breast cancer organization, and GE Healthcare, a leading global medical technology, pharmaceutical diagnostics and…

By Girl Power News , in News , at October 26, 2022

Susan G. Komen®, the world’s leading breast cancer organization, and GE Healthcare, a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, are partnering for the first time to support the Susan G Komen’s Metastatic Breast Cancer (MBC) Impact Series.

Every person deserves personalized breast cancer care options. In continuing its support of Susan G. Komen and efforts to improve outcomes for the breast cancer community, GE Healthcare has made a commitment to help Komen provide critical educational programs for the MBC community.

GE Healthcare’s investment will support the Susan G. Komen’s MBC Impact Series to ensure that people living with MBC and their loved ones have a safe and collaborative space to gather information to help make decisions for improved physical and emotional health.

“As a leader in imaging and healthcare innovation, GE Healthcare has shown its commitment to the MBC community through its investment in groundbreaking imaging agents that highlight estrogen receptor-positive tumors in patients whose breast cancer has recurred or spread,” said Victoria Wolodzko Smart, Senior Vice President of Mission at Komen. “GE Healthcare’s goals are aligned with our goal to conquer aggressive and deadly breast cancers and this partnership will help us bring critically needed access to the latest information on imaging, treatments and innovations to empower MBC patients.”

“Being diagnosed with MBC is difficult and there is a lot to learn about the disease and possible treatment options. Being able to learn directly from leading experts is critical for us to stay alive,” said Johnson. “Knowledge is power and providing the MBC community with the latest information is crucial to having a productive relationship with my oncologist. I love having access to the MBC experts through the MBC Impact Series because it reaffirms my faith in the medical community as a whole.”

While improvements in early detection and treatments led to a 42 percent reduction in the breast cancer mortality rate in the U.S. from 1989-2019, nearly 44,000 people in the U.S. will lose their lives to breast cancer this year, and almost all of these deaths are attributed to MBC.

“This stark reality is driving research discoveries at a rapid pace, so it is crucial for MBC patients to have access to evidence-based, easily accessible information from trusted experts to help them understand their disease and make timely decisions about their treatment,” said Wolodzko Smart.

For evidence-based information on MBC or to learn about the MBC Impact Series, visit

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit or call 1-877 GO KOMEN. Connect with us on social at

GE Healthcare is the $17.7 billion healthcare business of GE ( NYSE: GE). As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 48,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

Follow us on Facebook, LinkedIn, Twitter, and Insights for the latest news, or visit our website for more information.

CONTACT: Amanda Skahan
Susan G. Komen
[email protected]

Mathilde Bouscaillou
GE Healthcare
+33 6 47 00 82 71
[email protected]